当前位置: X-MOL 学术Antivir. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1JR-FL in the setting of post-exposure prophylaxis in NOD/SCID/Jak3−/− mice transplanted with human PBMCs
Antiviral Research ( IF 4.5 ) Pub Date : 2017-09-08 , DOI: 10.1016/j.antiviral.2017.09.003
Hiromi Ogata-Aoki 1 , Nobuyo Higashi-Kuwata 2 , Shin-Ichiro Hattori 3 , Hironori Hayashi 2 , Matthew Danish 4 , Manabu Aoki 5 , Chiemi Shiotsu 6 , Yumi Hashiguchi 7 , Akinobu Hamada 8 , Hisataka Kobayashi 9 , Hironobu Ihn 6 , Seiji Okada 10 , Hiroaki Mitsuya 11
Affiliation  

Employing NOD/SCID/Jak3−/− mice transplanted with human PBMCs (hNOJ mice) and replication-competent, red-fluorescent-protein (mCherry; mC)-labeled HIV-1JR-FL (HIVmC), we examined whether early antiretroviral treatment blocked the establishment of HIV-1 infection. The use of hNOJ mice and HIVmC enabled us to visually locate infection foci and to examine the early dynamics of HIVmC infection without using a large amount of antiretroviral unlike in non-human primate models. Although when raltegravir (RAL) administration was begun 1 day after intraperitoneal (ip) inoculation of HIVmC, no plasma p24 or plasma HIV-1-RNA (pRNA) were detected in 10 of 12 hNOJ (hNOJmCRAL+) mice as assessed on the last day of the 14-day continuous twice-daily RAL administration, all 10 untreated hNOJmC (hNOJmCRAL−) mice became positive for p24 and pRNA and had significantly swollen lymph nodes in peritoneal cavity and abundant p24+/mC+/CD3+/CD4+ T cells and p24+/mC+/CD68+ monocytes/macrophages were identified in their omenta and mesenteric lymphoid tissues/lymph nodes upon necropsy of the mice on day 14. In 12 hNOJmCRAL+ mice, no significantly swollen lymph nodes were seen compared to hNOJmCRAL− mice; however, in the omentum of the 2 hNOJmCRAL+ mice that were positive for pRNA and in site RNA, mC+/p24+/CD3+/CD83+ cells were identified, suggesting that viral breakthrough occurred later in the observation period. The present data suggest that the use of hNOJ mouse model and HIVmC may shed light on the study of early-phase dynamics of HIV-1 infection and cellular events in post-exposure/pre-exposure prophylaxis.



中文翻译:


在移植人 PBMC 的 NOD/SCID/Jak3−/− 小鼠暴露后预防中,拉替拉韦可阻断红色荧光蛋白 (mCherry) 标记的 HIV-1JR-FL 的感染性



使用移植了人 PBMC 的 NOD/SCID/Jak3 −/−小鼠(hNOJ 小鼠)和具有复制能力的红色荧光蛋白(mCherry; mC)标记的 HIV-1 JR-FL (HIV mC ),我们检查了是否早期抗逆转录病毒治疗阻止了 HIV-1 感染的形成。与非人类灵长类动物模型不同,hNOJ 小鼠和 HIV mC的使用使我们能够直观地定位感染灶并检查 HIV mC感染的早期动态,而无需使用大量抗逆转录病毒药物。尽管在腹膜内 ( ip ) 接种 HIV mC 1 天后开始给予拉替拉韦 (RAL),但根据评估,在 12 只 hNOJ (hNOJ mC RAL+ ) 小鼠中,有 10 只未检测到血浆 p24 或血浆 HIV-1-RNA (pRNA)。在连续每日两次 RAL 给药 14 天的最后一天,所有 10 只未治疗的 hNOJ mC (hNOJ mC RAL− ) 小鼠均呈 p24 和 pRNA 阳性,腹膜腔淋巴结明显肿胀,p24 + /mC + / 丰富第 14 天尸检小鼠时,在其网膜和肠系膜淋巴组织/淋巴结中鉴定出 CD3 + /CD4 + T 细胞和 p24 + /mC + /CD68 +单核细胞/巨噬细胞。 在 12 只 hNOJ mC RAL+小鼠中,与 hNOJ mC RAL−小鼠相比,没有观察到明显肿胀的淋巴结;然而,在 pRNA 和位点RNA 呈阳性的 2 只 hNOJ mC RAL+小鼠的网膜中,发现了 mC + /p24 + /CD3 + /CD83 +细胞,表明病毒突破发生在观察期后期。目前的数据表明,hNOJ 小鼠模型和 HIV mC的使用可能有助于研究 HIV-1 感染的早期动态以及暴露后/暴露前预防中的细胞事件。

更新日期:2017-09-08
down
wechat
bug